How Will Biologies Fit Into Healthcare Reform?With so many variables, it's hard to predict what kind of market will exist for biologies and other specialty drugs in 2014. Current trends may provide some insight.

摘要

Oct. 6, 2011, could become a red-letter day in the annals of healthcare policy. On that day, the Institute of Medicine took a big step forward in the national discussion about the finite quality of healthcare resources. In its recommendations to the Department of Health and Human Services on how to develop a minimum benefit package for health plans to be offered through the coming state healthcare exchanges, the IOM took the view that the scope of the benefits should be determined not by services but by costs. If HHS follows through on the IOM's recommendations, we could get as close to the R word as we have ever gotten in this country. Then again, nobody wants to hear about rationing.